Community oncology treatment patterns and clinical effectiveness in metastatic castration-resistant prostate cancer (mCRPC) patients who progressed after docetaxel.
Arthur C. Houts
Research Funding - Sanofi
Daniel Hennessy
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
Mark S. Walker
Research Funding - Sanofi
Leonardo Nicacio
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
Honoraria - Sanofi
Stephen F. Thompson
Employment or Leadership Position - Sanofi
Paul J. E. Miller
No relevant relationships to disclose
Bradley G. Somer
No relevant relationships to disclose